|
|
|
|
LEADER |
00000cmm a22000004a 4500 |
001 |
musev2_83833 |
003 |
MdBmJHUP |
005 |
20230905052629.0 |
006 |
m o d |
007 |
cr||||||||nn|n |
008 |
201020s2020 nyu o 00 0 eng d |
020 |
|
|
|a 9781479861439
|
035 |
|
|
|a (OCoLC)1273306473
|
040 |
|
|
|a MdBmJHUP
|c MdBmJHUP
|
100 |
1 |
|
|a Fisher, Jill A.
|e Verfasser.
|4 aut
|
245 |
1 |
0 |
|a Adverse Events :
|b Race, Inequality, and the Testing of New Pharmaceuticals /
|c Jill A. Fisher.
|
264 |
|
1 |
|a New York, NY
|b New York University Press
|c [2020]
|
264 |
|
3 |
|a Baltimore, Md. :
|b Project MUSE,
|c 2021
|
264 |
|
4 |
|c ©[2020]
|
300 |
|
|
|a 1 online resource:
|b 9 black and white illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Anthropologies of American Medicine: Culture, Power, and Practice
|
520 |
|
|
|a Explores the social inequality of clinical drug testing and its effects on scientific resultsImagine that you volunteer for the clinical trial of an experimental drug. The only direct benefit of participating is that you will receive up to.
|
546 |
|
|
|a In English.
|
588 |
|
|
|a Description based on print version record.
|
650 |
|
7 |
|a SOCIAL SCIENCE / Anthropology / General.
|2 bisacsh
|
650 |
|
4 |
|a validity.
|
650 |
|
4 |
|a study compensation.
|
650 |
|
4 |
|a social world.
|
650 |
|
4 |
|a social network.
|
650 |
|
4 |
|a social inequality.
|
650 |
|
4 |
|a social inequalities.
|
650 |
|
4 |
|a serial participation.
|
650 |
|
4 |
|a screen failure.
|
650 |
|
4 |
|a risk.
|
650 |
|
4 |
|a research staff.
|
650 |
|
4 |
|a research participation.
|
650 |
|
4 |
|a reputation.
|
650 |
|
4 |
|a region.
|
650 |
|
4 |
|a race.
|
650 |
|
4 |
|a qualifying.
|
650 |
|
4 |
|a public health.
|
650 |
|
4 |
|a profit.
|
650 |
|
4 |
|a phase I.
|
650 |
|
4 |
|a phase I trials.
|
650 |
|
4 |
|a phase I industry.
|
650 |
|
4 |
|a phase I clinical trials.
|
650 |
|
4 |
|a pharmaceutical industry.
|
650 |
|
4 |
|a participation.
|
650 |
|
4 |
|a opportunism.
|
650 |
|
4 |
|a model organism.
|
650 |
|
4 |
|a methods.
|
650 |
|
4 |
|a informed consent.
|
650 |
|
4 |
|a inclusion-exclusion criteria.
|
650 |
|
4 |
|a clinic;clinical trial culture;clinical trials;clinics;confinement;consumption;decision making;demographics;drug development;economic interests;economic motivations;economic need;economic risk;epistemology;health-promoting behavior;healthy volunteers;identity;imbricated stigma.
|
650 |
|
4 |
|a United States.
|
655 |
|
7 |
|a Electronic books.
|2 local
|
710 |
2 |
|
|a Project Muse.
|e distributor
|
830 |
|
0 |
|a Book collections on Project MUSE.
|
856 |
4 |
0 |
|z Texto completo
|u https://projectmuse.uam.elogim.com/book/83833/
|
945 |
|
|
|a Project MUSE - Custom Collection
|